Cargando…

Optimal treatment and stochastic modeling of heterogeneous tumors

In this work we review past articles that have mathematically studied cancer heterogeneity and the impact of this heterogeneity on the structure of optimal therapy. We look at past works on modeling how heterogeneous tumors respond to radiotherapy, and take a particularly close look at how the optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Badri, Hamidreza, Leder, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994177/
https://www.ncbi.nlm.nih.gov/pubmed/27549860
http://dx.doi.org/10.1186/s13062-016-0142-5
_version_ 1782449274848542720
author Badri, Hamidreza
Leder, Kevin
author_facet Badri, Hamidreza
Leder, Kevin
author_sort Badri, Hamidreza
collection PubMed
description In this work we review past articles that have mathematically studied cancer heterogeneity and the impact of this heterogeneity on the structure of optimal therapy. We look at past works on modeling how heterogeneous tumors respond to radiotherapy, and take a particularly close look at how the optimal radiotherapy schedule is modified by the presence of heterogeneity. In addition, we review past works on the study of optimal chemotherapy when dealing with heterogeneous tumors. Reviewers: This article was reviewed by Thomas McDonald, David Axelrod, and Leonid Hanin.
format Online
Article
Text
id pubmed-4994177
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49941772016-08-24 Optimal treatment and stochastic modeling of heterogeneous tumors Badri, Hamidreza Leder, Kevin Biol Direct Review In this work we review past articles that have mathematically studied cancer heterogeneity and the impact of this heterogeneity on the structure of optimal therapy. We look at past works on modeling how heterogeneous tumors respond to radiotherapy, and take a particularly close look at how the optimal radiotherapy schedule is modified by the presence of heterogeneity. In addition, we review past works on the study of optimal chemotherapy when dealing with heterogeneous tumors. Reviewers: This article was reviewed by Thomas McDonald, David Axelrod, and Leonid Hanin. BioMed Central 2016-08-23 /pmc/articles/PMC4994177/ /pubmed/27549860 http://dx.doi.org/10.1186/s13062-016-0142-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Badri, Hamidreza
Leder, Kevin
Optimal treatment and stochastic modeling of heterogeneous tumors
title Optimal treatment and stochastic modeling of heterogeneous tumors
title_full Optimal treatment and stochastic modeling of heterogeneous tumors
title_fullStr Optimal treatment and stochastic modeling of heterogeneous tumors
title_full_unstemmed Optimal treatment and stochastic modeling of heterogeneous tumors
title_short Optimal treatment and stochastic modeling of heterogeneous tumors
title_sort optimal treatment and stochastic modeling of heterogeneous tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994177/
https://www.ncbi.nlm.nih.gov/pubmed/27549860
http://dx.doi.org/10.1186/s13062-016-0142-5
work_keys_str_mv AT badrihamidreza optimaltreatmentandstochasticmodelingofheterogeneoustumors
AT lederkevin optimaltreatmentandstochasticmodelingofheterogeneoustumors